Diana Ernst, RPh

Increased demand for ibuprofen oral suspension products due to a surge in 3 circulating viruses prompted the Agency to issue compounding guidance.

Donanemab is an antibody therapy that targets a modified form of deposited amyloid-β peptide called N3pG.

Results showed vaccine efficacy of 83.7% against RSV-LRTD, defined by 2 or more symptoms.

Leqembi is a humanized IgG1 monoclonal antibody directed against aggregated soluble and insoluble forms of amyloid beta.

By identifying existing medications that may be repurposed for dementia, clinicians may be able to provide faster treatment for those in need.

Researchers used data from the State Unintentional Drug Overdose Reporting System in order to assess trends in gabapentin-involved overdose deaths.

AXS-07 is an oral agent that consists of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug, and rizatriptan, a 5-HT1B/1D agonist.

AMX0035 is an oral, fixed-dose coformulation of sodium phenylbutyrate and taurursodiol, also known as ursodoxicoltaurine.

Concise drug information for molnupiravir and Paxlovid; the FDA granted Emergency Use to both oral antiviral therapies.

Several pharmacotherapies have been shown to reduce pain in patients with painful diabetic neuropathy.

AMX0035 is an oral, fixed-dose coformulation of sodium phenylbutyrate and taurursodiol, also known as ursodoxicoltaurine.

The independent study conducted by Dan Barouch, MD, PhD, et al of Beth Israel Deaconess Medical Center included a subset of participants from the COV2008 study.

The CDC is recommending that health care providers take a travel history for all suspected and confirmed cases of COVID-19.

Both Companies provided data demonstrating waning neutralizing antibody titers approximately 6 months after completion of the primary series.

The UK study aimed to investigate SARS-CoV-2 transmission and viral load in vaccinated and unvaccinated people with mild Delta variant infection.

The analysis included 49,357 patients undergoing LAAO procedures with the Watchman Left Atrial Appendage Closure device.

Anecdotal reports suggest that naltrexone, an opioid antagonist, may alleviate symptoms associated with CRPS.

Patients treated with the investigational subcutaneous risperidone injection experienced a statistically significant delay in the time to relapse.

The Centers for Disease Control and Prevention continues to recommend COVID-19 vaccination for all individuals 12 years of age and older.

The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to targeted areas of the brain.

The TeenCOVE study (ClinicalTrials.gov: NCT04649151) included over 3700 US adolescents aged 12 to less than 18 years.

Rimegepant is an oral calcitonin gene-related peptide receptor antagonist.

The safety of the vaccine in this patient population was based on data from 2260 adolescent participants.

Currently, the FDA-approved route of administration of Tysabri for MS is through intravenous infusion.

Hizentra is indicated for the treatment of adult patients with CIDP as maintenance therapy to prevent relapse of neuromuscular disability and impairment.

Based on the available information, the panel was unable to decide on next steps for the Janssen COVID-19 vaccine.

Telmisartan, an angiotensin II receptor blocker, is indicated for the treatment of hypertension.

Atogepant is an investigational orally administered calcitonin gene-related peptide (CGRP) receptor antagonist.

In Part 2 of the trial, patients 2-25 years of age received either risdiplam for 24 months or placebo for 12 months followed by risdiplam for 12 months.

The phase 2/3 KidCOVE study [ClinicalTrials.gov: NCT04796896] is evaluating the safety and effectiveness of the vaccine in healthy children between 6 months and less than 12 years of age.